President Sally Kornbluth

President Sally Kornbluth is a prominent cell biologist and academic administrator serving as the 18th president of the Massachusetts Institute of Technology. She assumed the role in 2023, succeeding L. Rafael Reif, after a distinguished tenure as provost of Duke University. Kornbluth's scientific career is renowned for pioneering research on apoptosis, or programmed cell death, and its implications for cancer and developmental biology. Her leadership is characterized by a commitment to interdisciplinary collaboration, ethical innovation, and expanding access to science and engineering education.

Early life and education

Sally Kornbluth was born in 1961 and grew up in Fair Lawn, New Jersey. She demonstrated an early aptitude for science, which was nurtured during her undergraduate studies at Williams College, where she earned a Bachelor of Arts in political science. A pivotal shift toward biochemistry occurred during a summer research fellowship at the Jackson Laboratory in Bar Harbor, Maine. This experience led her to pursue graduate studies at the University of Cambridge as a Marshall Scholar, where she conducted doctoral research in molecular biology at the Gurdon Institute under the mentorship of John Gurdon. Following her PhD, she completed postdoctoral training in cell cycle regulation at Rockefeller University in New York City under the guidance of James E. Rothman.

Academic career

Kornbluth began her independent academic career in 1994 at the Duke University School of Medicine, where she rose through the ranks to become the James B. Duke Professor of Pharmacology and Cancer Biology. She held several key administrative roles at Duke University, including vice dean for basic science within the medical school. Her administrative acumen was further recognized when she was appointed provost of Duke University in 2014, serving as the chief academic officer to then-president Richard H. Brodhead and later Vincent E. Price. In this capacity, she oversaw all of Duke's schools, including the Pratt School of Engineering, Duke Law School, and the Nicholas School of the Environment, and led initiatives in faculty development, interdisciplinary research, and affordability.

MIT presidency

Sally Kornbluth was selected as president of MIT following an extensive international search, becoming the second woman to lead the institution after Susan Hockfield. Her inauguration in 2023 coincided with the launch of MIT's Climate Project and ongoing debates about the societal role of artificial intelligence. Key early priorities of her administration have included bolstering the MIT Schwarzman College of Computing, advancing the MIT Jameel Clinic for machine learning in health, and reinforcing the institute's commitment to The Engine. She has also navigated complex issues related to academic freedom, campus climate, and the ethical governance of emerging technologies, often engaging with federal agencies like the National Science Foundation and the Department of Defense.

Research and scientific contributions

Kornbluth's laboratory made seminal discoveries in the biochemical pathways controlling apoptosis, particularly the role of cytochrome c and the caspase cascade in mitochondrial regulation. Her work elucidated how cells execute self-destruction during normal development and in response to DNA damage, research with profound implications for understanding carcinogenesis and designing novel chemotherapy agents. She collaborated extensively with other leading scientists, including Michael B. Yaffe and Michael O. Hengartner, and her findings have been published in prestigious journals such as *Science*, *Nature*, and *Cell*. Her contributions have been recognized with memberships in the American Academy of Arts and Sciences and the National Academy of Medicine.

Leadership and public engagement

Beyond laboratory and campus leadership, Kornbluth is an active voice on national science policy and education. She serves on the board of the Association of American Universities and has contributed to committees for the National Institutes of Health and the Howard Hughes Medical Institute. A strong advocate for STEM education and diversity in science, she has supported programs like MIT OpenCourseWare and QuestBridge. She is married to Daniel Lew, a professor of pharmacology, and they have two children. In public addresses, she frequently emphasizes the responsibility of institutions like MIT to address global challenges such as climate change, public health, and economic inequality through rigorous, ethically grounded research and innovation.

Category:American cell biologists Category:Presidents of the Massachusetts Institute of Technology Category:21st-century American women scientists